Your browser doesn't support javascript.
loading
Enhancing the affinity of novel GLS1 allosteric inhibitors by targeting key residue Lys320.
Zhu, Li; Chang, Xiujin; Zhang, Shengpeng; Bai, Xiumei; Finko, Alexander V; Xu, Xi; Bian, Jinlei; Liu, Xiaoping; Huang, Huidan.
Afiliação
  • Zhu L; Center of Drug Screening & Evaluation, Wannan Medical College, Wuhu, Anhui, 241000, PR China.
  • Chang X; Center of Drug Screening & Evaluation, Wannan Medical College, Wuhu, Anhui, 241000, PR China.
  • Zhang S; Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing, 210009, PR China.
  • Bai X; Center of Drug Screening & Evaluation, Wannan Medical College, Wuhu, Anhui, 241000, PR China.
  • Finko AV; Department of Chemistry, Lomonosov Moscow State University (MSU), Moscow, 119991, Russia.
  • Xu X; Department of Chemistry, Lomonosov Moscow State University (MSU), Moscow, 119991, Russia.
  • Bian J; Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing, 210009, PR China.
  • Liu X; Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing, 210009, PR China.
  • Huang H; Center of Drug Screening & Evaluation, Wannan Medical College, Wuhu, Anhui, 241000, PR China.
Future Med Chem ; 15(15): 1393-1414, 2023 Aug.
Article em En | MEDLINE | ID: mdl-37610850
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Future Med Chem Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Future Med Chem Ano de publicação: 2023 Tipo de documento: Article